Hematopoietic Stem Cell Transplant Clinical Trial
Official title:
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.
Patients undergoing hematopoietic stem cell transplantation (HSCT) deal with numerous physical and psychological symptoms during acute hospitalization and recovery. Of the few psychosocial interventions tailored to the needs of the HSCT population, most focus on the needs of patients in the pre-transplant phase or during the HSCT hospitalization, but not during the acute recovery period starting at 100-days post-HSCT. Hence, the investigators developed a remotely-delivered positive psychology intervention, Positive Affect in the Transplantation of Hematopoietic Stem Cells (PATH). This intervention encourages patients to perform simple and enjoyable structured activities that increase the intensity of positive thoughts and emotions. With this multi-site randomized clinical trial, the investigators aim to find out whether PATH can improve psychological distress and quality of life in HSCT survivors, compared to usual care, using validated assessment tools. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT02451462 -
Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients
|
N/A | |
| Terminated |
NCT01215981 -
Influenza Vaccine Post Allogeneic Transplant
|
N/A | |
| Recruiting |
NCT03613532 -
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
|
Phase 1 | |
| Completed |
NCT01337648 -
Radiation Biodosimetry in Children Undergoing Total Body Irradiation
|
N/A | |
| Recruiting |
NCT03250546 -
Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant
|
Phase 2 | |
| Not yet recruiting |
NCT05722210 -
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
|
||
| Recruiting |
NCT02982902 -
T Cell Therapy of Opportunistic Cytomegalovirus Infection
|
Early Phase 1 | |
| Completed |
NCT02441075 -
70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014
|
N/A | |
| Completed |
NCT04549038 -
Time Restricted Nutrition in Pediatric Stem Cell Transplant Recipients
|
N/A | |
| Completed |
NCT03886909 -
Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant
|
N/A | |
| Completed |
NCT03509051 -
Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation
|
N/A | |
| Terminated |
NCT02350777 -
T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
|
Phase 2 | |
| Completed |
NCT04853277 -
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients
|
N/A | |
| Completed |
NCT03378089 -
Music Therapy and Hematopoietic Stem Cell Transplant
|
N/A | |
| Completed |
NCT03039257 -
Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates
|
N/A | |
| Completed |
NCT03202849 -
A Randomized Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell Transplantation
|
N/A | |
| Completed |
NCT01504152 -
International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center
|
N/A | |
| Completed |
NCT01581164 -
Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation
|
N/A | |
| Completed |
NCT03759262 -
Ultra-high Dose Vitamin D for HSCT
|
N/A | |
| Recruiting |
NCT04263597 -
Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients
|
Phase 1/Phase 2 |